Clifton Mining Company Inc. (OTC : CFTN) ALPINE, UT, Jan. 16 /PRNewswire-FirstCall/ -- End Of Year Summary ------------------- In 2007, Clifton's joint venture partner discovered another gold-bearing zone. Known mineralization now include the Kiewit gold mineralization, the Cane Springs gold mineralization, and now the Rattler Ridge gold mineralization. Clifton has a significant investment in American Biotech Labs(R), LLC (ABL). ABL is a private biotech company that produces a silversol, a potent yet benign anti-pathogenic. ABL's annual sales increased by 25%, to $4 million in 2007 with ongoing research and patent filings. Clifton received a cash dispersment from ABL for the 2007 sales year. The Gold Properties ------------------- The Kiewit property has been intensively drilled and estimates range between 75,000-250,000 ounces of recoverable gold. The venture is progressing toward a full feasibility study. Increasing gold prices add significantly because to minable reserves, as higher values increase cut off grades. Phase one drilling has been completed at the Cane Springs mine. An additional gold bearing structure was found and drilled adjacent to the historic mine. Like the historic mine, high-grade gold values were found, with some drill sections showing multi-ounce values of gold. Initial estimates indicate that this area may contain 100,000-200,000 ounces of gold. Clifton has filed for a mine permit for the Cane Springs mine, and expects to have the permit in hand within the next few months. Phase one drilling on the Rattler Ridge project has been completed. A number of the completed drill holes penetrated gold mineralization. Phase two drilling is now being planned for the spring. Other Mining News ----------------- The management of Clifton has filed with the Department Of Oil, Gas, and Mining for another mine permit to cover the Clifton silver veins area of the property. Management expects that permit to be granted within the next few months. American Biotech Labs --------------------- New products including the new gel products that came on line in August helped achieve a significant increase in sales. Management expects that new accounts in Europe, Asia, Middle East, and Africa will start to purchase product by mid-2008. ABL completed its new production facility, including bottling, gel manufacturing, and tubing facilities in 2007. The new facility, increased monthly production capacity to 1.5 million bottles. The new plant has received government approval to produce product and the plant is currently in operation. The company expects a number of articles on the Silversol Technology(TM) to be published in 2008, including one in conjunction with testing completed by the U.S. Military and another related to the H5-N1 Bird Flu. Clifton trades on the U.S. OTC: (CFTN). Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. DATASOURCE: Clifton Mining Company CONTACT: Dr. Ken Friedman, President at (303) 642-0659; Keith Moeller, Vice President at (801) 756-1414 or see the websites at http://www.cliftonmining.com/ and http://www.americanbiotechlabs.com/

Copyright